A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission.
source https://www.sciencedaily.com/releases/2026/03/260315225121.htm
Extreme coastal flooding surges worldwide as rising seas rewrite 100-year
odds
-
Human-caused sea-level rise has significantly increased the frequency of
extreme coastal flooding worldwide, according to a new study led by a
Tulane Unive...
12 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment